 |
PDBsum entry 1i1j
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1i1j
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
98:5515-5520
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.
|
|
J.C.Lougheed,
J.M.Holton,
T.Alber,
J.F.Bazan,
T.M.Handel.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Melanoma inhibitory activity (MIA) is a 12-kDa protein that is secreted from
both chondrocytes and malignant melanoma cells. MIA has been reported to have
effects on cell growth and adhesion, and it may play a role in melanoma
metastasis and cartilage development. We report the 1.4-A crystal structure of
human MIA, which consists of an Src homology 3 (SH3)-like domain with N- and
C-terminal extensions of about 20 aa. each. The N- and C-terminal extensions add
additional structural elements to the SH3 domain, forming a previously
undescribed fold. MIA is a representative of a recently identified family of
proteins and is the first structure of a secreted protein with an SH3 subdomain.
The structure also suggests a likely protein interaction site and suggests that,
unlike conventional SH3 domains, MIA does not recognize polyproline helices.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. The structure of melanoma inhibitory activity
protein. -strands are
in blue, regions lacking regular secondary structure are in
green, 3[10] helices are in red, and disulfide bonds are in
gold. (A) View of the two sheets that
pack at right angles to each other. Sheet I is in front. 1 and 7 add onto
sheet II of the SH3 -sandwich.
The top of the barrel is toward the top of the page. (B) View
looking into one end (mouth) of the barrel. The 30s-40s loop
(analogous to the RT loop of SH3 domains) and the 60s-70s loop,
flank one mouth of the barrel. The N-terminal residues preceding
1 and the
C-terminal residues following 7 run along
the outside face of sheet II. A and B are on the same scale.
|
 |
Figure 4.
Fig. 4. Comparison of the SH3 polyproline helix binding
site to the analogous region in MIA. (A) Superposition of the
conserved residues in the polyproline helix binding site of
Sem-5 (red) and the corresponding residues in MIA (blue). Four
of six residues conserved in SH3 domains differ in MIA. Residue
numbering corresponds to MIA. Residues listed in parentheses are
those found in canonical SH3 domains. (B) View of the molecular
surfaces of MIA (Left) and the Sem-5 SH3 domain (Right). The
structure of Sem-5 is shown with its polyproline ligand bound.
Sem-5 residues colored in red are those that make up a triad of
conserved aromatic residues arranged approximately linearly on
the molecular surface. The dissimilarity of the corresponding
residues in MIA, F59, I83, and Q28 result in a much smoother
molecular surface that most likely does not recognize
polyproline helices.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
F.Wendler,
A.K.Gillingham,
R.Sinka,
C.Rosa-Ferreira,
D.E.Gordon,
X.Franch-Marro,
A.A.Peden,
J.P.Vincent,
and
S.Munro
(2010).
A genome-wide RNA interference screen identifies two novel components of the metazoan secretory pathway.
|
| |
EMBO J,
29,
304-314.
|
 |
|
|
|
|
 |
T.Schubert,
J.Schlegel,
R.Schmid,
A.Opolka,
S.Grassel,
M.Humphries,
and
A.K.Bosserhoff
(2010).
Modulation of cartilage differentiation by melanoma inhibiting activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP).
|
| |
Exp Mol Med,
42,
166-174.
|
 |
|
|
|
|
 |
J.Schmidt,
and
A.K.Bosserhoff
(2009).
Processing of MIA protein during melanoma cell migration.
|
| |
Int J Cancer,
125,
1587-1594.
|
 |
|
|
|
|
 |
R.R.Thangudu,
M.Manoharan,
N.Srinivasan,
F.Cadet,
R.Sowdhamini,
and
B.Offmann
(2008).
Analysis on conservation of disulphide bonds and their structural features in homologous protein domain families.
|
| |
BMC Struct Biol,
8,
55.
|
 |
|
|
|
|
 |
S.Lin,
M.Ikegami,
Y.Xu,
A.K.Bosserhoff,
A.M.Malkinson,
and
J.M.Shannon
(2008).
Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.
|
| |
Dev Biol,
316,
441-455.
|
 |
|
|
|
|
 |
S.Sandhya,
B.Pankaj,
M.K.Govind,
B.Offmann,
N.Srinivasan,
and
R.Sowdhamini
(2008).
CUSP: an algorithm to distinguish structurally conserved and unconserved regions in protein domain alignments and its application in the study of large length variations.
|
| |
BMC Struct Biol,
8,
28.
|
 |
|
|
|
|
 |
A.A.Lebedev,
A.A.Vagin,
and
G.N.Murshudov
(2006).
Intensity statistics in twinned crystals with examples from the PDB.
|
| |
Acta Crystallogr D Biol Crystallogr,
62,
83-95.
|
 |
|
|
|
|
 |
J.R.Mesters,
C.Barinka,
W.Li,
T.Tsukamoto,
P.Majer,
B.S.Slusher,
J.Konvalinka,
and
R.Hilgenfeld
(2006).
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.
|
| |
EMBO J,
25,
1375-1384.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Stoll,
S.Lodermeyer,
and
A.K.Bosserhoff
(2006).
Detailed analysis of MIA protein by mutagenesis.
|
| |
Biol Chem,
387,
1601-1606.
|
 |
|
|
|
|
 |
S.Arndt,
and
A.K.Bosserhoff
(2006).
TANGO is a tumor suppressor of malignant melanoma.
|
| |
Int J Cancer,
119,
2812-2820.
|
 |
|
|
|
|
 |
J.Tatzel,
I.Poser,
J.Schroeder,
and
A.K.Bosserhoff
(2005).
Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
|
| |
Pigment Cell Res,
18,
92.
|
 |
|
|
|
|
 |
J.Holton,
and
T.Alber
(2004).
Automated protein crystal structure determination using ELVES.
|
| |
Proc Natl Acad Sci U S A,
101,
1537-1542.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.Li,
Y.Zhang,
and
J.Skolnick
(2004).
Application of sparse NMR restraints to large-scale protein structure prediction.
|
| |
Biophys J,
87,
1241-1248.
|
 |
|
|
|
|
 |
R.Stoll,
C.Renner,
R.Buettner,
W.Voelter,
A.K.Bosserhoff,
and
T.A.Holak
(2003).
Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains.
|
| |
Protein Sci,
12,
510-519.
|
 |
|
|
|
|
 |
W.Li,
Y.Zhang,
D.Kihara,
Y.J.Huang,
D.Zheng,
G.T.Montelione,
A.Kolinski,
and
J.Skolnick
(2003).
TOUCHSTONEX: protein structure prediction with sparse NMR data.
|
| |
Proteins,
53,
290-306.
|
 |
|
|
|
|
 |
K.Wakamatsu,
T.Kageshita,
M.Furue,
N.Hatta,
Y.Kiyohara,
J.Nakayama,
T.Ono,
T.Saida,
M.Takata,
T.Tsuchida,
H.Uhara,
A.Yamamoto,
N.Yamazaki,
A.Naito,
and
S.Ito
(2002).
Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experience.
|
| |
Melanoma Res,
12,
245-253.
|
 |
|
|
|
|
 |
M.Moser,
A.K.Bosserhoff,
E.B.Hunziker,
L.Sandell,
R.Fässler,
and
R.Buettner
(2002).
Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice.
|
| |
Mol Cell Biol,
22,
1438-1445.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |